Ticker LaunchFiled, not priced · CRGT
Cortigent, Inc.
Cortigent, Inc. publicly filed a registration statement on Form S-1 on Mar 20, 2023 for a proposed initial public offering on NYSE American under the ticker CRGT, and has not yet priced. Its latest amendment was filed on May 13, 2026. Underwriters named in the filing: ThinkEquity.
Cortigent, Inc., through its predecessor Second Sight Medical Products, develops neurostimulation systems to help patients recover bodily functions. Its technology provides artificial vision and may restore muscle movement. Its first system, Argus II, is a retinal implant.
- Status
- Filed, not priced
- Ticker
- CRGT
- Exchange
- NYSE American
- First filed
- Mar 20, 2023
- Latest amendment
- May 13, 2026
- Underwriters
- ThinkEquity
- Sector
- Healthcare
- Country / state
- CA
More on this listing for subscribers
- Shares offered, over-allotment and shares outstanding after the offering
- Amendment history
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Mar 20, 2023
- Latest amendment May 13, 2026
- All filings on EDGAR CIK 1958489
Other companies in the IPO pipeline
- KINGTITAN TECHNOLOGY LtdMay 13, 2024
- Libera Gaming Operations, IncMar 15, 2024
- Suke LtdMar 12, 2024
- Skubbs Holdings LtdMar 4, 2024
- QQJ Inc.Feb 7, 2024
- Alopexx, Inc.Mar 7, 2022